Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$13.14 -0.23 (-1.72%)
At close: Sep 4, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Goodwill (2023 - 2024)

Tonix Pharmaceuticals Holding (TNXP) posted Goodwill of $965000.0 for Q1 2024, little changed on a QoQ basis from $965000.0 in Q4 2023.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Goodwill (2023 - 2024) Analysis & Trends

Tonix Pharmaceuticals Holding has reported Goodwill for 2 years, with the latest figure at $965000.0 in Q1 2024.

  • On a quarterly basis, Goodwill changed N/A year-over-year to $965000.0 in Q1 2024; TTM through Mar 2024 was $965000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $965000.0, changed N/A from the prior year.
  • Goodwill was $965000.0 for Q1 2024 at Tonix Pharmaceuticals Holding, roughly flat from $965000.0 in the prior quarter.
  • The five-year high for Goodwill was $965000.0 in Q2 2023, with the low at $965000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 Tonix Pharmaceuticals Holding 220.65 Mn 220.65 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 965,000.00
Dec 31, 2023 965,000.00
Sep 30, 2023 965,000.00
Jun 30, 2023 965,000.00